EU Rips Up Competition Rulebook To Allow Collaboration On Coronavirus
Medicines For Europe Welcomes European Commission’s Temporary Framework
A temporary framework has been adopted by the European Commission that will allow companies and associations to co-ordinate efforts to tackle the coronavirus pandemic without raising competition concerns. The move has been welcomed by the European off-patent industry.
You may also be interested in...
At a Medicines for Europe webinar on learning lessons from the COVID-19 pandemic, a clear consensus emerged that a continued co-ordination between industry, regulators and the European Commission was key to both effectively address the current crisis and ensure a greater level of preparedness for similar challenges in future.
In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national and EU level.
Speakers at a recent COVID-19 webinar discussed a number of issues related to the pandemic, including intellectual property protections, matching supply with demand, and what to do about excess manufacturing capacity once the crisis is over.